Helius Medical Technologies (OTCMKTS:HSDT) Stock Price Down 6.4%

Helius Medical Technologies Inc (OTCMKTS:HSDT) shares were down 6.4% on Thursday . The stock traded as low as $0.84 and last traded at $0.88, approximately 89,036 shares changed hands during mid-day trading. A decline of 72% from the average daily volume of 314,961 shares. The stock had previously closed at $0.94.

Separately, Zacks Investment Research raised shares of Helius Medical Technologies from a “sell” rating to a “hold” rating in a research report on Wednesday, January 15th.

The company’s 50-day moving average price is $1.02 and its two-hundred day moving average price is $1.31.

Helius Medical Technologies (OTCMKTS:HSDT) last released its earnings results on Tuesday, November 12th. The company reported ($0.22) earnings per share for the quarter, hitting the Thomson Reuters’ consensus estimate of ($0.22). The company had revenue of $0.15 million during the quarter, compared to the consensus estimate of $0.30 million.

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Millennium Management LLC grew its position in shares of Helius Medical Technologies by 627.9% during the 3rd quarter. Millennium Management LLC now owns 207,895 shares of the company’s stock valued at $343,000 after buying an additional 179,336 shares during the last quarter. Morgan Stanley grew its position in shares of Helius Medical Technologies by 302.7% during the 2nd quarter. Morgan Stanley now owns 14,072 shares of the company’s stock valued at $31,000 after buying an additional 10,578 shares during the last quarter. Renaissance Technologies LLC grew its position in shares of Helius Medical Technologies by 1,132.9% during the 4th quarter. Renaissance Technologies LLC now owns 166,505 shares of the company’s stock valued at $161,000 after buying an additional 153,000 shares during the last quarter. Finally, Virtu Financial LLC bought a new stake in shares of Helius Medical Technologies during the 4th quarter valued at about $83,000.

Helius Medical Technologies Company Profile (OTCMKTS:HSDT)

Helius Medical Technologies, Inc is a medical technology company focused on neurological wellness. The Company focuses on developing, licensing or acquiring non-invasive platform technologies that amplify the brain’s ability to heal itself. The Company is engaged in the development of its product, the portable neuromodulation stimulator (PoNS) device.

Featured Story: What is a Tariff?

Receive News & Ratings for Helius Medical Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Helius Medical Technologies and related companies with MarketBeat.com's FREE daily email newsletter.